Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
about
Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activationMedicinal cannabisAdvances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum DisorderFluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects.Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of Mesial Temporal Lobe EpilepsyPotential effects of cannabidiol as a wake-promoting agent.The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory.Neuroprotective properties of cannabigerol in Huntington's disease: studies in R6/2 mice and 3-nitropropionate-lesioned mice.Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor.Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders.Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cellsCannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells.Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotectionA Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis.HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid.Molecular Targets of Cannabidiol in Neurological DisordersAnalysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndromePathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells.Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report.Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell deathMarijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy.Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT(1A) receptors without diminishing nervous system function or chemotherapy efficacy.The influence of cannabinoids on generic traits of neurodegeneration.Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.The role of cannabinoids and leptin in neurological diseases.Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPARγ and 5-HT1A receptors.Identification of Terpenoid Chemotypes Among High (-)-trans-Δ9- Tetrahydrocannabinol-Producing Cannabis sativa L. CultivarsModulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive CannabinoidCannabidiol Exposure During Neuronal Differentiation Sensitizes Cells Against Redox-Active Neurotoxins.Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5YAPP+ cells through PPARγ involvement.Cannabinoid effects on β amyloid fibril and aggregate formation, neuronal and microglial-activated neurotoxicity in vitro.Changes in endocannabinoid receptors and enzymes in the spinal cord of SOD1(G93A) transgenic mice and evaluation of a Sativex(®) -like combination of phytocannabinoids: interest for future therapies in amyotrophic lateral sclerosis.Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats.An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol.Potential of Cannabidiol for the Treatment of Viral Hepatitis.Cannabidiol rescues acute hepatic toxicity and seizure induced by cocaine.Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy.Cannabidiol Oil for Decreasing Addictive Use of Marijuana: A Case Report.The bright side of psychoactive substances: cannabinoid-based drugs in motor diseases.Cannabidiol promotes browning in 3T3-L1 adipocytes.
P2860
Q24605572-893A959C-E79C-4A09-90CE-33CC064D18EAQ26769626-CD0EF4E2-A8B8-4DA5-9E86-97E4A1393578Q26781265-AB5E3143-BA1C-495D-874F-B0FCE6B97443Q30376980-4C09D18F-8128-4E46-9EA3-AD5496099E35Q30842130-93D4623A-4A41-4AD3-A62A-25BF75413CC8Q33621686-0D00EE4C-F0F9-41E1-9217-7F2F763BA5CAQ33623423-9E729E4A-97C8-4DDD-BAF9-53CF272D5642Q34440282-865906C7-BD9B-40E6-AB04-DF17406067D9Q34545629-68390A04-8279-458C-B473-D4A91992DCB3Q34557613-7A71C614-162F-494D-BCC8-E7185823FBEBQ34700334-53682E15-8DC0-4A38-99B6-1A455FF79FA9Q35186239-05659971-27B6-461A-BF3B-9C1A7F6FA218Q35499568-8EB5452A-DC8C-4322-9C17-D1E1FD776CFEQ35865445-BE6266FC-7BAB-4162-A11F-06AB1D74B075Q36077672-4847F682-946C-4098-8811-3E4C04E483DDQ36157649-F4F0B602-09D6-4250-892F-D34AED32A6E4Q36719661-3FBCDF00-BABB-41FE-9326-6DF44692A9A9Q36965753-01418666-9DC3-47EA-AB98-35D05E893A38Q37401982-0B30D019-5564-4607-AC3D-78DD63E32641Q37424055-6AFD8817-552E-45EF-8714-E7D14656B6D7Q37512670-5A3A999C-BF8C-466D-B46C-53F24F53171EQ37671286-07B3EC74-414F-416A-BD6C-3AFFED532C88Q38156518-F1A8D229-E8A2-4C2C-B604-F0872F1BD78BQ38261541-946D87C4-6B2B-410A-901B-90D4E0D94DC8Q38423817-E8CF7DF0-A7B9-471F-9064-CBB16FD348B1Q38572902-4414CA00-8936-4815-AB7E-DA74DD69EAC0Q38598501-FA243A5C-62A3-45F8-9357-3604965FE133Q38634379-49EF647B-7033-43E8-A89F-3803EC445AFFQ38967514-A02C0F7B-78E0-4A0B-B7DB-83C2FAEFABD4Q39052200-D6028302-7996-432A-B8A3-510CC3453B68Q39096624-A11696DC-0FB1-436A-B156-154123C1330CQ39215660-00E08A95-98EF-4897-B9D1-2581E84656EDQ39360618-610AE25C-055C-445A-B51A-2F6ED97E19F4Q39431492-EF03DCBB-22E9-48B5-8195-93434D8B804FQ40312314-A69D1194-1FEE-428D-A2CC-EA4DBD62A132Q40527320-62840691-B9DF-4FB6-A275-A4467ADA8418Q41560648-2FB84609-71B5-40AC-AA7F-24A6EDDA76A5Q42163235-227FC525-6F93-43C1-A042-70E0A562041EQ42495608-2BF53F76-C021-44EB-84AC-210482498B2BQ42811858-B47DD27E-0977-4D02-BF63-9D94C2335179
P2860
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cannabidiol for neurodegenerat ...... ons for this phytocannabinoid?
@en
type
label
Cannabidiol for neurodegenerat ...... ons for this phytocannabinoid?
@en
prefLabel
Cannabidiol for neurodegenerat ...... ons for this phytocannabinoid?
@en
P2093
P2860
P50
P921
P1476
Cannabidiol for neurodegenerat ...... ons for this phytocannabinoid?
@en
P2093
Javier Fernández-Ruiz
M Ruth Pazos
Onintza Sagredo
P2860
P304
P356
10.1111/J.1365-2125.2012.04341.X
P407
P577
2013-02-01T00:00:00Z